Prudential Financial’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36.5K | Buy |
+10,135
| New | +$36.5K | ﹤0.01% | 2363 |
|
2024
Q1 | – | Sell |
-110,105
| Closed | -$336K | – | 2674 |
|
2023
Q4 | $336K | Sell |
110,105
-3,900
| -3% | -$11.9K | ﹤0.01% | 2278 |
|
2023
Q3 | $342K | Sell |
114,005
-101,900
| -47% | -$306K | ﹤0.01% | 2211 |
|
2023
Q2 | $807K | Sell |
215,905
-23,500
| -10% | -$87.9K | ﹤0.01% | 1917 |
|
2023
Q1 | $802K | Sell |
239,405
-36,300
| -13% | -$122K | ﹤0.01% | 1852 |
|
2022
Q4 | $1.33M | Sell |
275,705
-18,930
| -6% | -$91.1K | ﹤0.01% | 1553 |
|
2022
Q3 | $1.68M | Sell |
294,635
-84,700
| -22% | -$482K | ﹤0.01% | 1436 |
|
2022
Q2 | $2.69M | Sell |
379,335
-67,780
| -15% | -$481K | ﹤0.01% | 1227 |
|
2022
Q1 | $3.23M | Buy |
447,115
+64,600
| +17% | +$466K | ﹤0.01% | 1231 |
|
2021
Q4 | $3.42M | Buy |
+382,515
| New | +$3.42M | ﹤0.01% | 1248 |
|
2021
Q3 | – | Sell |
-66,875
| Closed | -$1.44M | – | 2587 |
|
2021
Q2 | $1.44M | Sell |
66,875
-3,560
| -5% | -$76.4K | ﹤0.01% | 1650 |
|
2021
Q1 | $4.35M | Buy |
+70,435
| New | +$4.35M | 0.01% | 1086 |
|